Page last updated: 2024-12-08
aluminum lithium silicate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
spodumene: RN given refers to (HAlSi2O6)Li salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 166597 |
| MeSH ID | M0137320 |
Synonyms (19)
| Synonym |
|---|
| spodumene |
| 1302-37-0 |
| 12068-40-5 |
| einecs 235-098-6 |
| aluminium lithium silicate |
| silicic acid (h2sio3), aluminum lithium salt (2:1:1) |
| beta-spodumene |
| spodumene (alli(sio3)2) |
| aluminum lithium silicate |
| 12646-13-8 |
| silicic acid, aluminum lithium salt |
| aluminum(iii) lithium silicate |
| DTXSID60926631 |
| alpha-spodumene |
| Q26841348 |
| aluminum;lithium;bis(oxidanidyl)-oxidanylidene-silane |
| aluminum;lithium;dioxido(oxo)silane |
| lithium;oxido-oxo-[(2-oxo-1,3,2,4-dioxasilalumetan-4-yl)oxy]silane |
| mfcd00058768 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 28.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.36) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||